Lekhim-Vilnius - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,221,195 | 939,464 | 483,731 | 458,575 | 3,529,027 | 3,716,874 | 2,017,661 | 2,229,765 |
| Profit before tax | 68,930 | 59,310 | 27,327 | -7,674 | -162,361 | 373,102 | 216,380 | 112,292 |
| Net profit | 58,590 | 48,370 | 23,224 | -15,136 | -200,894 | 313,514 | 179,809 | 73,671 |
| Equity | 154,060 | 202,430 | 225,655 | 210,518 | 9,624 | 323,138 | 502,947 | 576,618 |
| Liabilities | 626,934 | 622,674 | 400,748 | 283,694 | 1,993,964 | 1,546,809 | 2,349,532 | 285,690 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 38,280 | 0 | 0 |
| Current assets | 780,994 | 825,104 | 626,403 | 494,212 | 2,003,588 | 1,831,667 | 2,852,479 | 862,308 |
| Total assets | 780,994 | 825,104 | 626,403 | 494,212 | 2,003,588 | 1,869,947 | 2,852,479 | 862,308 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 72,327 | 82,035 | 43,013 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +22.6% | -23.1% | -48.5% | -5.2% | +669.6% | +5.3% | -45.7% | +10.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.5% | 5.9% | 3.7% | -3.1% | -10.0% | 16.8% | 6.3% | 8.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 38.0% | 23.9% | 10.3% | -7.2% | -2087.4% | 97.0% | 35.8% | 12.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.8% | 5.1% | 4.8% | -3.3% | -5.7% | 8.4% | 8.9% | 3.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.6% | 6.3% | 5.6% | -1.7% | -4.6% | 10.0% | 10.7% | 5.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.1 | 3.1 | 1.8 | 1.3 | 207.2 | 4.8 | 4.7 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,221,195 | 939,464 | 483,731 | 458,575 | 2,646,836 | 3,716,874 | 1,862,514 | 2,058,308 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Lekhim-Vilnius - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-10-18 | 2022-11-03 | 0.01 |
| 2022-09-16 | 2022-10-03 | 0.01 |
| 2022-08-23 | 2022-09-05 | 0.01 |
| 2022-07-18 | 2022-08-03 | 0.01 |
| 2022-04-19 | 2022-05-04 | 0.01 |
Lekhim-Vilnius - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Lekhim-Vilnius, UAB (code 304170526) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €2.23M, up 10.5% year on year, after €2.02M in 2024 and €3.72M in 2023. Net profit was €73.7K in 2025, down from €179.8K in 2024 and €313.5K in 2023, which reduced the net profit margin to 3.3% from 8.9% and 8.4% in the prior two years. The balance sheet strengthened in terms of capital structure, with equity of €576.6K and liabilities of €285.7K at the end of 2025, compared with €502.9K equity and €2.35M liabilities in 2024. Total assets fell to €862.3K from €2.85M a year earlier. Latest ratios show an equity ratio of 66.9%, debt-to-equity of 0.50, ROE of 12.8%, ROA of 8.5%, and asset turnover of 2.59x. Revenue per employee stood at €2.23M and profit per employee at €73.7K in 2025.